Back to search results

Study for Healthcare Workers with Post-traumatic Stress Disorder and Moral Injury

This study is for healthcare workers who have experienced trauma at work and are struggling with psychological distress, including conditions like Post-traumatic Stress Disorder (PTSD) and moral injury. The goal is to find helpful interventions. You would participate in two phases. In the first phase, lasting two weeks, you would have four sessions of either "Medical Music" or "Narrative Writing." Later, if you continue to the second phase, you might receive "Prolonged Exposure Therapy" or "Interpersonal Psychotherapy." The study is looking at how well it can recruit and enroll participants. To join, you need to be a healthcare worker over 18, speak English, be medically stable, and able to give informed consent. If you are on psychiatric medication, it needs to have been stable for 60 days.

Study design
This interventional study plans to enroll 120 participants. It involves random assignment to different behavioral interventions.
What's involved
You would complete 4 sessions over 2 weeks in Phase I. The record does not specify commitments for Phase II.
Compensation
Not stated in the trial record.
Follow-up
Feasibility indicators for recruitment and enrollment are measured at Baseline and at week 2.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04626050

General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to Occupational Trauma

Recruiting
NAAges 18+InterventionalTreatment
Weill Medical College of Cornell University
~120 participants
Updated 2026-06-22 on ClinicalTrials.gov
What's tested:Medical MusicNarrative WritingProlonged Exposure TherapyInterpersonal Psychotherapy

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility Indicator: Recruitment (Phase I)
Measured over Baseline
+9 more outcomes measured

Conditions

Post-traumatic Stress Disorder
Moral Injury

Explore related trials

Moral InjuryPost-Traumatic Stress DisorderPsychological Distress

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • JoAnn Difede, PhD · PRINCIPAL_INVESTIGATOR · Weill Medical College of Cornell University

Who to contact

Olivia Baryluk, BS
[email protected]
212-821-0783
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Any healthcare worker providing medical care or support who has experienced occupational-related trauma
English-speaking
Age \>18
Medically stable
Able to provide informed consent and function at an intellectual level sufficient to allow accurate completion of all assessment instruments
If on psychotropic medication stable for prior 60 days

Exclusion

Current significant unstable medical illness precluding regular session attendance or assessment completion
Participants who in the investigator's judgment pose a current homicidal, suicidal, or other risk
Lifetime or current diagnosis of schizophrenia or other psychotic disorder
Participation in a clinical trial or concurrent evidence-based treatment for psychiatric conditions or PTSD during the previous 3 months.

What this trial measures

  • Feasibility Indicator: Recruitment (Phase I)Baseline

    Feasibility assessment will include recruitment defined as number of individuals interested in the intervention.

  • Feasibility Indicator: Recruitment (Phase II)Post-Phase I Assessment at week 2

    Feasibility assessment will include: recruitment defined as number of individuals interested in the intervention.

  • Feasibility Indicator: Enrollment (Phase I)Baseline

    Feasibility assessment will include enrollment defined as number of participants signing the informed consent form.

  • Feasibility Indicator: Enrollment (Phase II)Post-Phase I Assessment at approximately week 2

    Feasibility assessment will include enrollment defined as number of individuals beginning phase II.

  • Feasibility Indicator: Retention (Phase I)Post-Phase I Assessment at approximately week 2

    Feasibility assessment will include retention defined as the number of participants completing the full course of Phase I interventions.

  • Feasibility Indicator: Retention (Phase II)Post-Phase II Assessment at approximately week 7

    Feasibility assessment will include retention defined as the number of participants completing the full course of Phase II interventions.

  • Acceptability Indicator: Satisfaction (Phase I)Post-Phase I Assessment at approximately week 2

    Acceptability and treatment satisfaction will be rated with a Likert scale.

  • Acceptability Indicator: Satisfaction (Phase II)Post-Phase II Assessment at approximately week 7

    Acceptability and treatment satisfaction will be rated with a Likert scale.

  • Preliminary Efficacy as Measured by Change in Clinician-Administered PTSD Scale Score (Phase I)Start of Phase I to approximately 2 weeks

    Change in Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) Score. Total Scores range from 0-80. Higher scores indicate greater symptom severity.

  • Preliminary Efficacy as Measured by Change in Clinician-Administered PTSD Scale Score (Phase II)Start of Phase II to approximately 5 weeks

    Change in Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) Score. Total Scores range from 0-80. Higher scores indicate greater symptom severity.